Peginterferon alpha-2a add-on to siRNA JNJ-73763989 in untreated patients with HBeAg-positive chronic hepatitis B virus (HBV) infection: the phase 2 REEF-IT study

Journal:

Gut

Published:

2025-11-05

DOI:

10.1136/gutjnl-2025-336592

Affiliations:

11

Authors:

14

Go to article

Institutions	Authors	Share
Johnson & Johnson, Belgium, Belgium	4.000000	0.29
Johnson & Johnson, United States of America (USA)	3.000000	0.21
Queen Mary University of London (QMUL), United Kingdom (UK)	1.000000	0.07
University of Toronto (U of T), Canada	1.000000	0.07
Vall d'Hebron University Hospital (HUVH), ICS, Spain	1.000000	0.07
KTU Farabi Hospital International, Turkey	1.000000	0.07
Kaohsiung Medical University Chung-Ho Memorial Hospital (KMUH), KMU, Taiwan	1.000000	0.07
Musashino Red Cross Hospital, Japan	1.000000	0.07
Centre de Recherche sur l’Inflammation (CRI), France	0.500000	0.04
AP-HP Beaujon Hospital, France	0.500000	0.04

Interested in Medical Microbiology?